Sema4C overexpression inhibits E-cadherin expression and upregulates Vimentin to induce EMT in hepatocellular carcinoma24, breast cancer20, CR cervical cancer17 and PR lung cancer18. This evidence concerns the gene SEMA4C and medical procedure.